Label-Free LC-MS^e in Tissue and Serum Reveals Protein Networks Underlying Differences between Benign and Malignant Serous Ovarian Tumors

• Wouter Wegdam ,

  * E-mail: W.Wegdam@amc.uva.nl

  Affiliation Department of Gynecology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

  ⨯
• Carmen A. Argmann,

  Affiliation Department of Genetics and Genomic Sciences, Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America

  ⨯
• Gertjan Kramer,

  Affiliation Clinical Proteomics Group, Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

  ⨯
• Johannes P. Vissers,

  Affiliation Waters Corporation MS Technologies Center, Manchester, United Kingdom

  ⨯
• Marrije R. Buist,

  Affiliation Department of Gynecology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

  ⨯
• Gemma G. Kenter,

  Affiliation Department of Gynecology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

  ⨯
• Johannes M. F. G. Aerts,

  Affiliation Clinical Proteomics Group, Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

  ⨯
• Danielle Meijer,

  Affiliation Department of Gynecology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

  ⨯
• Perry D. Moerland

  Affiliation Bioinformatics Laboratory, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

  ⨯